Excision a life science company that focuses on the development and commercialization of gene editing therapeutics... Read more
Excision a life science company that focuses on the development and commercialization of gene editing therapeutics... Read more
News
Mar 11, 2020
Benzinga
Excision BioTherapeutics: Excision BioTherapeutics Announces Data Presentation at CROI from IND-Enabling Non-Human Primate studies of EBT-001, supporting a CRISPR Gene Editing Technology for HIV Elimination
Nov 22, 2019
Benzinga
Excision BioTherapeutics: Excision BioTherapeutics Presents Data to Support HIV Cure Using CRISPR Gene Editing Technology
Nov 18, 2019
StreetInsider
Press Release: Excision BioTherapeutics : CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure
Jul 02, 2019
4-traders
Excision BioTherapeutics: HIV Eliminated from the Genomes of Living Animals; Excision BioTherapeutics Advancing the Innovation to Clinical Development
Nov 06, 2018
BioPortfolio
Excision BioTherapeutics: Excision BioTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 02, 2018
BioPortfolio
Excision BioTherapeutics: Excision BioTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 19, 2018
BioPortfolio
Excision BioTherapeutics: Excision BioTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250
Nov 13, 2017
BioCentury
Excision BioTherapeutics: Excision licenses new CRISPR IP
Sep 06, 2017
BioCentury
Excision BioTherapeutics: Excision raises $10M seed round
Sep 05, 2017
The Business Journals
Excision BioTherapeutics: Gene-editing company taking on HIV raises $10M
Excision BioTherapeutics Competitors
1
2
3
4
5
6
7
8
9
10